Nov 7 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO
* Acerus reports third quarter 2017 financial results
* Acerus Pharmaceuticals Corporation - product revenue for Q3 2017 grew to $1.6 million versus $1.4 million for Q3 2016
* Acerus Pharmaceuticals Corporation qtrly loss per share $0.01
* Acerus Pharmaceuticals Corporation- total Q3 revenues of $1.9 million compared to $1.6 million same prior year period